Abstract
Rhein is one of the main components of Rheum. It is widely used for the treatment of tumor, virus, diabetic nephropathy, bacterial infection and inflammatory, and it shows excellent clinical application value. Here, recent studies on the pharmacological activity and synthesis of rhein and its derivatives were reviewed and future direction was also briefly discussed, hoping to provide beneficial information for the research of rhein and its derivatives.
Keywords: Derivative, pharmacological activity, rhein, structure modification, synthesis.
Current Traditional Medicine
Title:Pharmacology of Rhein and Advancement in the Synthesis of Its Derivatives
Volume: 2 Issue: 1
Author(s): Qiu-He Chen, Rong-Biao Pi and Jing-Kao Chen
Affiliation:
Keywords: Derivative, pharmacological activity, rhein, structure modification, synthesis.
Abstract: Rhein is one of the main components of Rheum. It is widely used for the treatment of tumor, virus, diabetic nephropathy, bacterial infection and inflammatory, and it shows excellent clinical application value. Here, recent studies on the pharmacological activity and synthesis of rhein and its derivatives were reviewed and future direction was also briefly discussed, hoping to provide beneficial information for the research of rhein and its derivatives.
Export Options
About this article
Cite this article as:
Chen Qiu-He, Pi Rong-Biao and Chen Jing-Kao, Pharmacology of Rhein and Advancement in the Synthesis of Its Derivatives, Current Traditional Medicine 2016; 2 (1) . https://dx.doi.org/10.2174/2215083802666160620131215
DOI https://dx.doi.org/10.2174/2215083802666160620131215 |
Print ISSN 2215-0838 |
Publisher Name Bentham Science Publisher |
Online ISSN 2215-0846 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Animal Models of Obesity and Metabolic Syndrome: Potential Tools for Alzheimers Disease Research
Current Alzheimer Research Lipid Disorders in Diabetes Mellitus and Current Management
Current Pharmaceutical Analysis How to Keep Oxidative Stress Under Control?
Current Nutrition & Food Science Calcifediol – More than the Stepchild of CKD-MBD Therapy?
Current Vascular Pharmacology Current Drug Nano-targeting Strategies for Improvement in the Diagnosis and Treatment of Prevalent Pathologies such as Cardiovascular and Renal Diseases
Current Drug Targets Inflammatory Syndrome in Chronic Kidney Disease: Pathogenesis and Influence on Outcomes
Inflammation & Allergy - Drug Targets (Discontinued) Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor Inhibitors as Anti-Angiogenic Agents in Cancer Therapy
Recent Patents on Anti-Cancer Drug Discovery Chelating Agents for Metal Intoxication
Current Medicinal Chemistry Impact of Nutrition Transition and Resulting Morbidities on Economic and Human Development
Current Diabetes Reviews Association of Soluble Adhesion Molecule and C-Reactive Protein Levels with Silent Brain Infarction in Patients with and Without Type 2 Diabetes
Current Neurovascular Research Glomerular Endothelium and its Impact on Glomerular Filtration Barrier in Diabetes: Are the Gaps Still Illusive?
Current Medicinal Chemistry Role of the Renin-Angiotensin-Aldosterone System in the Pathogenesis of Atherosclerosis
Current Pharmaceutical Design Immunossupressant and Organ Transplantation: Immunophilins Targeting Agent and Alternative Therapies
Current Medicinal Chemistry NO Signaling Through cGMP in Renal Tissue Fibrosis and Beyond: Key Pathway and Novel Therapeutic Target
Current Medicinal Chemistry Micro RNA: An Epigenetic Regulator of Type 2 Diabetes
MicroRNA Susceptibility Genes in Hypertension
Current Pharmaceutical Design Hyperglycemia to Nephropathy via Transforming Growth Factor Beta
Current Diabetes Reviews EDITORIAL [Hot Topic-II: PPAR Ligands and Cardiovascular Disorders: Friend or Foe (Guest Editors: Pitchai Balakumar and Gowraganahalli Jagadeesh)]
Current Molecular Pharmacology Hypoxia and Oxidative Stress in the Causation of Diabetic Retinopathy
Current Diabetes Reviews Interventions to Reduce Cardiovascular Risk in Children with Type 1 Diabetes
Current Diabetes Reviews